Filitsa Bender's research while affiliated with University of Pittsburgh and other places

Publications (39)

Article
Disseminated candidiasis caused by the fungus Candida albicans is a major clinical problem in individuals with kidney disease and accompanying uremia; disseminated candidiasis fatality is twice as common in patients with uremia as those with normal kidney function. Many antifungal drugs are nephrotoxic, making treatment of these patients particular...
Article
Technology-assisted cognitive-behavioral therapy (CBT) interventions have been conducted for symptoms including depression, pain, and fatigue in patients with chronic illnesses but not in end-stage renal disease (ESRD). The purpose of this study was to pilot the feasibility and acceptability of a technology-assisted CBT intervention in ESRD patient...
Article
Full-text available
Background and objectives: Current therapies for hyponatremia have variable effectiveness and tolerability, and in certain instances, they are very expensive. We examined the effectiveness, safety, and tolerability of urea for the treatment of inpatient hyponatremia. Design, setting, participants, & measurements: We identified all patients hospi...
Article
The peritoneal dialysis (PD) patient population has grown rapidly in the past few years with concern over poor early outcomes. We report 6-month outcomes of incident PD patients in an experienced program with a strong focus on quality care. We analyzed data from an Institutional Review Board (IRB)- approved registry of all incident PD patients from...
Conference Paper
Full-text available
GFR BEFORE, AT START AND 1ST VISIT AFTER STARTING PD Yan Dorneich, Filitsa Bender, Heena Sheth, Beth Piraino University of Pittsburgh School of Medicine, Pittsburgh PA, USA. A number of studies have examined the loss of residual kidney function (RKF) on PD over years but there are few data on whether starting PD has an immediate impact on RKF. We s...
Article
Full-text available
Automated peritoneal dialysis (APD) is one of the fastest growing dialysis modalities. It is unknown whether sleep and mood are disturbed while performing repeated overnight exchanges. In this report, we aim to describe and compare the prevalence of sleep-disordered breathing (SDB), periodic limb movements (PLMS), poor sleep quality (SQ), and depre...
Article
Full-text available
Unlabelled: ♦ Background: Daily gentamicin cream exit-site prophylaxis reduces peritoneal dialysis (PD)-related gram-negative infections. However, there is a concern about the potential for increasing gentamicin resistance with the long-term use of prophylactic gentamicin. This study evaluated the incidence of gentamicin-resistant PD-related inf...
Article
Studies have shown that a single-item question might be useful in identifying patients with limited health literacy. However, the utility of the approach has not been studied in patients receiving maintenance peritoneal dialysis (PD). We assessed health literacy in a cohort of 31 PD patients by administering the Rapid Estimate of Adult Literacy in...
Article
This review is focused on minimizing complications and avoiding harm in peritoneal dialysis (PD) patients. Issues related to planning for PD are covered first, with emphasis on PD versus hemodialysis outcomes. Catheter types and insertion techniques are described next, including relevant recommendations by the International Society for Peritoneal D...
Article
Full-text available
Encapsulating peritoneal sclerosis (EPS) is a life-threatening complication of peritoneal dialysis. Few data are available from the United States about the incidence of EPS over time. To examine that question, we retrospectively examined our PD registry, in existence for 30 years, to identify patients with EPS. All other data were collected prospec...
Article
Home dialysis in the United States, both home hemodialysis and peritoneal dialysis, peaked in the early 1990s. Since then, there has been a striking increase in the numbers and proportion of patients on in-center home hemodialysis (HD). As of 2008, there were approximately 27,000 patients on peritoneal dialysis (PD) and 2,455 on home HD with over 3...
Article
The Kidney Disease Outcomes Quality Initiative guidelines for peritoneal dialysis (PD) emphasize the need for quality improvement interventions to improve outcomes in PD. Here, we report 17 years experience of initiatives focused on lowering peritonitis rates in a single PD program. This institutional review board-approved retrospective analysis us...
Article
Full-text available
In this Practice Point commentary, we discuss Wiggins et al.'s systematic review of the treatment of peritonitis, a serious problem in peritoneal dialysis patients. Wiggins and co-workers reported that most antibiotic classes were similarly effective for the treatment of peritonitis. Despite the limited data available, the investigators found that...
Article
The Kidney Disease Outcomes Quality Initiative (K/ DOQI) 2006 recommended a minimum weekly Kt/V of 1.7 for peritoneal dialysis (PD) patients while emphasizing the importance of keeping the patient free of uremic symptoms. We examined a symptom score index [Pittsburgh Symptom Score (PSS)] designed to evaluate uremic symptoms to determine if the scor...
Article
Peritoneal dialysis (PD) related infections continue to be a serious complication for PD patients. Peritonitis can be associated with pain, hospitalization and catheter loss as well as a risk of death. Peritonitis risk is not evenly spread across the PD population or programs. Very low rates of peritonitis in a program are possible if close attenti...
Article
Full-text available
Infection is the Achilles heel of peritoneal dialysis. Exit site mupirocin prevents Staphylococcus aureus peritoneal dialysis (PD) infections but does not reduce Pseudomonas aeruginosa or other Gram-negative infections, which are associated with considerable morbidity and sometimes death. Patients from three centers (53% incident to PD and 47% prev...
Article
Full-text available
To compare the accuracy and convenience of 3 methods for measuring drain volume for peritoneal dialysis (PD) clearance studies. Prospective comparison of both automated PD (APD) and continuous ambulatory PD (CAPD) clearance study methods. Adults > or = 18 years old at 2 dialysis clinics. 28 PD patients with 43 clearance studies, 15 on CAPD and 28 o...
Article
Full-text available
To compare the small molecule clearances on tidal peritoneal dialysis (TPD) and intermittent peritoneal dialysis (IPD), controlling for dialysate flow rate. Alternating 8-hour treatments on IPD and TPD (2 of each in 6 patients), each treatment separated by 3 or more days [patients returning to continuous ambulatory peritoneal dialysis (CAPD) in the...
Article
Studies with 1.75 mmol/L calcium dialysate have shown that patients gain calcium from dialysate. Thus, hypercalcemia, especially when calcium compounds are used for phosphate control, is a commonly seen complication. Dialysate with 1.25 mmol/L calcium has been available since 1989. Little is known about calcium mass transfer (CMT) with dialysate of...
Article
Polycythemia in CAPD patients has been rarely described. Over an eight year period, 4 out of 123 CAPD patients (3%) were identified as having Hct values exceeding 50% for 1 month or longer. All of the 4 patients were insulin dependent diabetics (4/47 diabetic patients, 8.5%). Charts were reviewed on 3 of these 4 patients. Polycythemia developed aft...

Citations

... In these patients, the increased levels of urea in the bloodstream drove the downregulation of the phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K)/protein kinase B (AKT) pathway, causing the inhibition of glucose uptake through the hyperactivation of the glycogen synthase kinase 3β (GSK3β). 129 This is consistent with the finding that inhibiting GSK3β in a mouse model of kidney disease restores ROS production and the fungicidal activity of neutrophils to protect from systemic candidiasis. These observations suggest the possibility of repurposing selective GSK3β inhibitors, such as lithium chloride, to treat fungal disease. ...
... In 27 validation studies, 9 studies are from the USA[37,[49][50][51][52][53][54][55][56]. 7 studies are from Iran[40, 57-62]. 1 study each is from South Korea [63], Japan [64], the Netherlands [65], Poland [66], UK [67], Ireland [61] and United Arab Emirates [36]. ...
... Within therapies for chronic non-severe hyponatremia, oral urea as an oral osmotic diuretic that increases urinary water excretion appears to be a very effective and safe treatment for the prevention of possibly associated morbidity and mortality [36]. Since, it has been tolerated poorly due to its taste, there are newer, proven safe and efficient, oral American formulations enhancing its palatability [37]. The dose of oral urea is 0.25-0.5 g/kg/day and it should be increased in cases of a higher urine osmolality, usually >30 g/day [38]. ...
... However, there are very few studies reporting spectrum of predialysis patients' symptoms in peritoneal dialysis (PD) patients and little is known about the burden of symptoms of predialysis patients especially PD patients [6]. In addition, unlike many predialysis indictors linking to the patients outcomes, such as GFR, serum albumin [7,8], calcium [9,10], body mass index [11], and comorbidities [8,12], the potential predictive value of patients' predialysis symptoms have not been fully elucidated. ...
... Between 45% and 80% of patients with end-stage renal disease (ESRD) struggle with sleep-related problems; nearly half of individuals with CKD have these problems at the beginning of their illness [4]. Compared to patients receiving continuous ambulatory peritoneal dialysis (PD), patients receiving automated PD appear to have less severe sleep-related breathing disorders (SBD) [5]. There appears to be a decreased incidence of sleep-related issues after kidney transplantation [6]. ...
... • Nous recommandons que chaque programme mesure et surveille, au moins une fois par an, l'incidence des infections liées aux cathéters (1C [17]. Les incidences rapportées des infections du site de sortie varient considérablement, allant de 0,06 à 0,42 épisode par an [13,[18][19][20][21][22][23][24]. Dans l'essai HONEYPOT portant sur 371 patients en DP dans 26 centres de 3 pays (Australie, Nouvelle-Zélande et Singapour) entre 2008 et 2012, le taux d'infection du site de sortie était de 0,29 épisode par an dans le groupe de soins standard utilisant la mupirocine contre 0,37 épisode par an dans le groupe de traitement antibactérien au miel [22]. ...
... Other studies of health literacy in PD patients have used the REALM or Short Test of Functional Health Literacy in Adults to measure health literacy (13)(14)(15). Those tools have been widely used for research purposes, but are difficult to apply in clinical practice. ...
... Elevating serum albumin level, maintaining the sufficiency of dialysis and reducing the volume load of patients play a vital role in lowering the hospitalization rate of PD patients. [22][23][24] In this retrospective study, no death was observed in the HD and PD groups within 5 years, indicating that the competition risk for death is partially reduced by the hospitalization, which is consistent with previous findings. [25] ...
... (2015) also did not nd signi cant differences between health awareness and PD [11]. A possible explanation is that the respondents have high economic and knowledge levels; as previously discussed, PD-related information can be easily obtained, and acquiring knowledge is convenient. ...
... In other words, self-care behavior in patients with CKD are complex as individuals may have different perspectives on their illness, and their priorities, expectations for support, trust in healthcare providers and the healthcare system, and how they go about carrying-out their self-care may vary. Additionally, studies conducted up to now have investigated health literacy in CKD using tools for measuring only the functional aspects of health literacy, such as numeracy skills and reading comprehension [26][27][28], and have not captured health literacy scales that are important in healthcare delivery, such as the ability to appraise health information or engagement with healthcare providers [29]. Given that only a limited number of studies have comprehensively identified challenges that patients with CKD patients experience in understanding and applying health information in their daily life, further studies are needed in this context. ...